Stephen I. Katz Early Stage Investigator Research Project Grant (R01 Basic Experimental Studies with Human Required)
ID: 351638Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Income Security and Social Services

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/351638

Additional Information

http://grants.nih.gov/grants/guide/pa-files/PAR-24-076.html
Timeline
    Description

    The National Institutes of Health (NIH) is offering the Stephen I. Katz Early Stage Investigator Research Project Grant (R01), aimed at supporting innovative research projects by early-stage investigators (ESIs) that signify a substantial change in research direction without the inclusion of preliminary data. This grant specifically targets basic experimental studies involving human participants, requiring applicants to provide a detailed explanation of how their proposed project diverges from their previous work, while aligning with the scientific missions of participating NIH Institutes and Centers. The funding opportunity encourages diversity and aims to stimulate novel approaches in biomedical research, with applications accepted until December 29, 2026. Interested applicants can find more information and contact NIH Grants Information at grantsinfo@nih.gov for inquiries.

    Point(s) of Contact
    grantsinfo@nih.gov
    Files
    Title
    Posted
    PAR-24-076-Full-Announcement.html
    PAR-24-076.html
    The Stephen I. Katz Early Stage Investigator Research Project Grant (R01) aims to support innovative research projects by early-stage investigators (ESIs) that represent a significant change in research direction, specifically those without preliminary data. The funding is intended for basic experimental studies involving human participants and requires a detailed description of how the proposed project diverges from the investigator's past work. Applications must not include preliminary data to qualify. The program encourages diversity and aims to stimulate innovative approaches in biomedical research consistent with participating National Institutes of Health (NIH) institutes' missions. Eligibility extends to various institutions including higher education and non-profit entities, with an emphasis on engaging underrepresented groups. Applications undergo rigorous review, focusing on significance, innovation, and approach. The funding opportunity is open for applications until December 29, 2026, with outlined key dates for submission and review processes. Overall, this grant seeks to foster novel scientific exploration while ensuring compliance with NIH's policies and guidelines.
    Similar Opportunities
    Stephen I. Katz Early Stage Investigator Research Project Grant (R01 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the Stephen I. Katz Early Stage Investigator Research Project Grant (R01 Clinical Trial Not Allowed) to support innovative research projects led by early-stage investigators (ESIs) that represent a significant change in research direction without prior preliminary data. Applicants must submit proposals that do not include preliminary data and must describe the proposed shift in research focus, aligning with the missions of participating NIH Institutes and Centers. This grant aims to foster groundbreaking research and promote workforce diversity among ESIs from various backgrounds, including higher education institutions, nonprofits, and local governments. The application period opens on December 29, 2023, with a submission deadline of December 28, 2026. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov, and additional details can be found at the provided link: https://grants.nih.gov/grants/guide/pa-files/PAR-24-075.html.
    Early Stage Investigator HIV/AIDS Research Using Nonhuman Primate (NHP) Models (R21 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Early Stage Investigator HIV/AIDS Research Using Nonhuman Primate (NHP) Models (R21 Clinical Trial Not Allowed)" aimed at supporting Early Stage Investigators (ESIs) in conducting innovative preclinical research on HIV/AIDS using NHP models. This grant initiative seeks to empower researchers who are within ten years of their terminal degree and have at least two years of postdoctoral experience, enabling them to explore new research directions that align with the NIH Strategic Plan for HIV and HIV-Related Research for FY 2021-2025. The funding provides a maximum of $400,000 over a two-year period, with applications due by September 7, 2025. Interested applicants can find more information and submission guidelines at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Maximizing Investigators Research Award (MIRA) for Early Stage Investigators (ESI) (R35 - Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting applications for the Maximizing Investigators' Research Award (MIRA) aimed at Early Stage Investigators (ESIs) under the Notice of Funding Opportunity (NOFO) PAR-23-145. This grant supports a comprehensive research program within the mission of the National Institute of General Medical Sciences (NIGMS), allowing eligible researchers to apply for up to $250,000 per year for a maximum of five years, with a requirement to dedicate at least 51% of their research efforts to the program. The MIRA program is designed to enhance scientific productivity and flexibility, enabling early-career scientists to explore significant research projects without the need for preliminary data, while also promoting diversity through a required Plan for Enhancing Diverse Perspectives (PEDP). Interested applicants should note that the application deadline is February 3, 2026, and can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    NIH Pathway to Independence Award (Parent K99/R00 Independent Basic Experimental Studies with Humans Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the Pathway to Independence Award (K99/R00), a federal grant aimed at supporting exceptional postdoctoral researchers in their transition to independent faculty positions while conducting basic experimental studies involving human subjects. This program is designed to facilitate a timely shift from mentored postdoctoral roles to independent research careers, providing funding for up to five years, divided into a mentored K99 phase (up to two years) and an independent R00 phase (up to three years), contingent upon successful transition to tenure-track or equivalent positions. Eligible applicants include a diverse range of institutions, such as Historically Black Colleges and Universities and Tribal Colleges, with key application deadlines starting May 10, 2024, and the final submission date set for May 7, 2027. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov or visit the program's webpage for additional details.
    NIH Exploratory/Developmental Research Grant Program (Parent R21 Basic Experimental Studies with Humans Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the Exploratory/Developmental Research Grant Program (Parent R21), aimed at supporting innovative early-stage research projects in the biomedical, behavioral, and clinical fields. This funding opportunity is specifically designed for basic experimental studies involving human participants, with a focus on developing novel techniques or methodologies that can significantly advance scientific understanding. Eligible applicants, including small businesses and various institutions, can receive funding of up to $275,000 over a two-year period, with applications accepted on a rolling basis until the close date of January 7, 2025. For further details, interested parties can contact the NIH OER Webmaster at FBOWebmaster@OD.NIH.GOV or visit the additional information link at http://grants.nih.gov/grants/guide/pa-files/PA-20-196.html.
    Small Grants for New Investigators to Promote Diversity in Health-Related Research (R21 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the "Small Grants for New Investigators to Promote Diversity in Health-Related Research" (R21 Clinical Trial Optional) to support new investigators from diverse backgrounds in conducting small research projects. This funding opportunity aims to facilitate the transition to independent research careers for individuals who have not previously secured over $125,000 in direct costs of research funding, specifically targeting those from historically underrepresented groups in biomedical research. The grants, which can last up to three years with a maximum direct cost of $125,000 annually, are intended to foster innovation and address health disparities in underserved populations. Interested applicants must submit their proposals by January 8, 2025, and can reach out to the NIH OER Webmaster at OERWebmaster03@od.nih.gov for further inquiries.
    NICHD Small Research Grant Program (R03 Basic Experimental Studies with Humans Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NICHD Small Research Grant Program (R03), which supports small clinical trials focused on basic experimental studies involving human participants. This funding opportunity aims to enhance understanding of fundamental phenomena without immediate application towards products or processes, aligning with the NICHD's mission in human development, behavior, and health. Grants are available for up to $50,000 in direct costs per year, with a maximum project duration of two years, and applications must be submitted by January 7, 2025. Interested applicants can find more information and application details at the NIH website or contact the NIH OER Webmaster at grantsinfo@nih.gov for assistance.
    Mentored Research Scientist Development Award (Parent K01 Independent Basic Experimental Studies with Humans Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the Mentored Research Scientist Development Award (K01), a federal grant aimed at supporting individuals in their pursuit of research independence in the biomedical, behavioral, or clinical sciences. This grant provides funding for a protected period of three to five years, allowing candidates to develop their research careers under the mentorship of experienced professionals, specifically focusing on basic experimental studies involving human participants. The program is designed to foster a diverse cohort of capable scientists to address national research needs, with applications opening on May 12, 2024, and deadlines extending through 2025. Interested applicants can find more information and contact NIH Grants Information at grantsinfo@nih.gov for inquiries.
    Independent Scientist Award (Parent K02 Independent Basic Experimental Studies with Humans Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the Independent Scientist Award (K02), a federal grant aimed at supporting outstanding scientists through salary support and "protected time" for intensive research over a period of three to five years. This opportunity is specifically designed for independent researchers conducting basic science experimental studies involving human subjects, which must align with the scientific missions of various NIH Institutes and Centers. The K02 award is crucial for fostering diversity in biomedical research and advancing scientific fields by enabling researchers to explore fundamental phenomena without immediate product applications in mind. Interested applicants must hold a doctoral degree, demonstrate independent research support, and commit at least 75% of their professional effort to research. The application submission opens on May 13, 2024, with a close date of May 7, 2027. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov or visit the opportunity's webpage at https://grants.nih.gov/grants/guide/pa-files/PA-24-180.html.
    NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00 - Independent Basic Experimental Studies with Humans Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Cancer Institute (NCI), is offering the K99/R00 Pathway to Independence Award aimed at supporting early-stage postdoctoral researchers transitioning to independent research positions. This funding opportunity is designed for postdoctoral fellows with research or clinical doctoral degrees, focusing on studies involving human participants that meet the NIH definitions of clinical trials and basic research, particularly in cancer control, prevention, and data sciences. The program consists of a two-phase structure: the K99 phase provides up to two years of mentored support, while the R00 phase offers up to three years of independent research funding, contingent on progress and securing a faculty position. Interested applicants must adhere to strict guidelines and institutional nominations, with key deadlines approaching in January 2024. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov, and additional details can be found at the provided link: https://grants.nih.gov/grants/guide/pa-files/PAR-23-288.html.